['iron deficiency anaemia', 'iron deficiency anemia']
['iron isomaltoside/ferric derisomaltose', 'iron sucrose']

        Inclusion criteria includes:

          1. Men or women ≥ 18 years

          2. Subjects having IDA caused by different etiologies

          3. Subjects with intolerance to oral iron therapy or a need for rapid repletion of iron
             stores:

          4. Haemoglobin (Hb) ≤ 11 g/dL

          5. Transferrin Saturation (TSAT) < 20 %

          6. S-ferritin < 100 ng/mL

          7. Willingness to participate and signing the informed consent form

        Exclusion Criteria includes :

          1. Anemia predominantly caused by factors other than IDA

          2. Hemochromatosis or other iron storage disorders

          3. Previous serious hypersensitivity reactions to any IV iron compound

          4. Erythropoiesis stimulating agent (ESA) treatment

          5. Prior to screening or during the trial period; has or will be treated with a red blood
             cell transfusion, radiotherapy, and/or chemotherapy

          6. Will require a surgical procedure that necessitated general anesthesia prior to
             screening or during the trial period

          7. Alanine aminotransferase and/or aspartate aminotransferase > 3 times upper limit of
             normal

          8. Required dialysis for treatment of chronic kidney disease (CKD)

          9. Alcohol or drug abuse within the past 6 months

         10. Pregnant or nursing women
      